Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
This brief overview contrasts index and target date retirement funds, outlining core differences and practical tips to help you choose the right option.
25,442 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Memory demand is reshaping the sector, and Micron sits at the center. This guide explains what drives micron technolo...
Carvana's 2025 earnings outlook centers on cash flow, balance-sheet repair, and smarter growth. This guide breaks dow...
SpaceX's IPO excitement gave way to a pullback, leaving investors wondering about future gains. This guide breaks dow...
A recent price retreat for AMD has more to do with market nerves than a broken thesis. This article lays out why inve...
CoreWeave stock is front and center as data-center demand rises. With a growing backlog and expanding capacity plans,...
A big move by an asset manager can ripple through a stock’s price and its story. This article explains what asset man...
A surprise rally in Kingsoft Cloud Holdings stock grabbed attention as analysts spotlight AI-driven growth. This arti...
Adobe is navigating a fast-changing software landscape in 2026. This guide breaks down the 2026 earnings outlook, key...
Standard Chartered reaffirms a lofty Bitcoin target as Trump underscores China risk, pointing to crypto sovereignty a...
This week brought a notable rise for Corcept Therapeutics as investors reacted to a major catalyst. Learn what drove ...
As AMD prepares to report its second-quarter results, a bullish outlook centered on AI demand could dominate the conv...